Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison

Affiliations

¹ Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada. Electronic address: amattman@providencehealth.bc.ca.
² Department of Clinical Laboratory Medicine, McGill University Health Centre, 1001 Decarie Boulevard, Montreal, QC H4A 3J1, Canada. Electronic address: Brian.gilfix@mcgill.ca.
³ Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.
⁴ Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Centre for Heart Lung Innovation, University of British Columbia, BC V6Z 1Y6, Canada. Electronic address: mdmrco@mail.ubc.ca.
⁵ DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: barry.kyle@dynalife.ca.
⁶ DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: michelle.parker@dynalife.ca.
⁷ DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: terence.agbor@dynalife.ca.
⁸ Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, BC Children's & BC Women's Hospitals, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Room 2J10 Vancouver, BC V6H 3V4, Canada. Electronic address: benjamin.jung@Sickkids.ca.
⁹ Department of Laboratory Medicine and Genetics, Trillium Health Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
¹⁰ Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, BC Children's & BC Women's Hospitals, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Room 2J10 Vancouver, BC V6H 3V4, Canada. Electronic address: vilte.barakauskas@cw.bc.ca.
¹¹ Department of Laboratory Medicine and Genetics, Trillium Health Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Electronic address: andrea.vaags@thp.ca.
¹² DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: mathew.estey@dynalife.ca.
¹³ Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, BC Children's & BC Women's Hospitals, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Room 2J10 Vancouver, BC V6H 3V4, Canada.
¹⁴ Department of Laboratory Medicine and Genetics, Trillium Health Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Electronic address: marsha.speevak@thp.ca.

PMID: 32387440
DOI: 10.1016/j.clinbiochem.2020.05.001

Comparative Study

Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison

Andre Mattman et al. Clin Biochem. 2020 Jul.

. 2020 Jul:81:27-33.

doi: 10.1016/j.clinbiochem.2020.05.001. Epub 2020 May 6.

Authors

Affiliations

¹ Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada. Electronic address: amattman@providencehealth.bc.ca.
² Department of Clinical Laboratory Medicine, McGill University Health Centre, 1001 Decarie Boulevard, Montreal, QC H4A 3J1, Canada. Electronic address: Brian.gilfix@mcgill.ca.
³ Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.
⁴ Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Centre for Heart Lung Innovation, University of British Columbia, BC V6Z 1Y6, Canada. Electronic address: mdmrco@mail.ubc.ca.
⁵ DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: barry.kyle@dynalife.ca.
⁶ DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: michelle.parker@dynalife.ca.
⁷ DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: terence.agbor@dynalife.ca.
⁸ Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, BC Children's & BC Women's Hospitals, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Room 2J10 Vancouver, BC V6H 3V4, Canada. Electronic address: benjamin.jung@Sickkids.ca.
⁹ Department of Laboratory Medicine and Genetics, Trillium Health Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
¹⁰ Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, BC Children's & BC Women's Hospitals, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Room 2J10 Vancouver, BC V6H 3V4, Canada. Electronic address: vilte.barakauskas@cw.bc.ca.
¹¹ Department of Laboratory Medicine and Genetics, Trillium Health Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Electronic address: andrea.vaags@thp.ca.
¹² DynaLIFE Medical Labs, 200, 10150 102 St, Edmonton, AB T5J 5E2, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, 5B4.02 Walter C, Mackenzie Health Sciences Centre, Edmonton, AB T6G 2R7, Canada. Electronic address: mathew.estey@dynalife.ca.
¹³ Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, BC Children's & BC Women's Hospitals, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Room 2J10 Vancouver, BC V6H 3V4, Canada.
¹⁴ Department of Laboratory Medicine and Genetics, Trillium Health Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Electronic address: marsha.speevak@thp.ca.

PMID: 32387440
DOI: 10.1016/j.clinbiochem.2020.05.001

Abstract

Background: Laboratory confirmation of alpha-1-antitrypsin (A1AT) deficiency may be achieved by multiple methods. Here, we compare the relative comprehensiveness and efficiency of pathogenic variant (PV) detection of four different protocols utilized at different diagnostic centres in Canada.

Methods: Diagnostic results from 2011 to 2018 at clinical laboratories in British Columbia (BC), Alberta (AB), Ontario (ON), and Québec (QC) were reviewed. The four labs utilize the following protocols: BC-CGID (serum A1AT Concentration/Genotyping/Isoelectric focussing (IEF)/SERPINA1 DNA sequencing), AB-CID (serum A1AT Concentration/IEF/DNA sequencing), ON-CD (serum A1AT Concentration/DNA sequencing), and QC-G (Genotyping). As the respective catchment areas varied in size and ethnic composition, the comprehensiveness of PV detection was assessed by comparing the frequency of individual genotypes to the ZZ genotype, which is clearly identified by all protocols.

Results: Collectively 5399 index patients were tested identifying 396 ZZ genotypes. Serum A1AT concentration as a determinant of further testing efficiently identified PV. ON-CD had the highest detection rate for PV; genotypes with at least one PV, other than S, Z or F, were identified at 0.67/ZZ as compared to <0.2/ZZ (all others). However, ON-CD had the highest rates of undefined molecular variants (UMV) (0.16/ZZ) or likely benign variants (LBV) (0.08/ZZ), compared to all others (<0.12/ZZ and < 0.06/ZZ, respectively). The F variant was identified at 0.10/ZZ, only in the ON-CD and the AB-CID protocols. Collectively, M_Malton was the next most common variant, identified as a compound heterozygous genotype at 0.04/ZZ, only in the ON-CD and BC-CGID protocols.

Conclusion: Strategies which readily detect variants across the full coding sequence of SERPINA1 detect more PV as well as more UMV and LBV.

Keywords: A1AT deficiency; Alpha-1-antitrypsin; Diagnostic yield; Gene sequencing; Isoelectric focussing; Targeted genotyping.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison

Affiliations

Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison

Authors

Affiliations

Abstract

Conflict of interest statement

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Research Materials

Miscellaneous